MSX2: A Non-Coding RNA Molecule as A Potential Drug Target (G4488)

Target Name: MSX2

NCBI ID: G4488

MSX2

MSX2: A Non-Coding RNA Molecule as A Potential Drug Target

MSX2 (HOX8) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to investigate, and recent studies have shed new light on its role in various biological processes.

MSX2 is a heat- shock transcription factor (HSTF), which means it is expressed in high levels in the cytoplasm of cells under stress, such as those undergoing cell division or infection. HSTFs play a crucial role in regulating gene expression in response to these stressors, and are thought to be involved in the development and progression of various diseases.

One of the key features of MSX2 is its ability to induce a positive feedback loop, where the level of MSX2 protein synthesis is influenced by the level of MSX2 mRNA. This self-regulation mechanism allows MSX2 to control its own expression, and is a hallmark of its HSTF function.

MSX2 has been shown to play a role in various biological processes, including cell growth, apoptosis, and inflammation. For example, studies have shown that MSX2 can promote the growth of cancer cells, and is involved in the development of various types of cancer, including breast, ovarian, and prostate cancer.

In addition to its role in cancer, MSX2 has also been shown to be involved in autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. These studies have suggested that MSX2 may be involved in the regulation of immune cells, and that its dysfunction may contribute to the development of these diseases.

Furthermore, MSX2 has also been shown to be involved in neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. These studies have suggested that MSX2 may be involved in the regulation of neural cell survival and proliferation, and that its dysfunction may contribute to the development of these diseases.

In conclusion, MSX2 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and function, as well as its ability to induce a positive feedback loop, make it an attractive target for researchers to investigate. Further studies are needed to fully understand its role in various biological processes, and to determine its potential as a drug.

Protein Name: Msh Homeobox 2

Functions: Acts as a transcriptional regulator in bone development. Represses the ALPL promoter activity and antagonizes the stimulatory effect of DLX5 on ALPL expression during osteoblast differentiation. Probable morphogenetic role. May play a role in limb-pattern formation. In osteoblasts, suppresses transcription driven by the osteocalcin FGF response element (OCFRE). Binds to the homeodomain-response element of the ALPL promoter

The "MSX2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MSX2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets